Acute Coronary Syndromes (ACS) News

  • So Long, Plavix, What a Ride! Clopidogrel Patent Expires So Long, Plavix, What a Ride! Clopidogrel Patent Expires Expiration of the clopidogrel patent draws a close to a "fascinating era" in cardiovascular medicine, say experts, having had its largest impact in the ACS and poststenting settings. Yet even as the patent expires there remain some unanswered questions, particularly given the emergence of platelet function and genetic testing for clopidogrel metabolism.
  • FDA Approves Generic Versions of Plavix Alert FDA Approves Generic Versions of Plavix Nine pharmaceutical companies will produce 2 different generic versions of the ubiquitous blood thinner.
 

Acute Coronary Syndromes (ACS) Perspectives

 

Acute Coronary Syndromes (ACS) Journal Articles

 
All material on this website is protected by copyright, Copyright © 1994-2012 by WebMD LLC. This website also contains material copyrighted by 3rd parties.